Cancer - Chemotherapy.

Cancer chemotherapy and biotherapy = principles and practice / by: (Language materials, printed)

Cancer Chemotherapy in Clinical Practice by: (Language materials, printed)

The role of microtubules in cell biology, neurobiology, and oncology by: (Language materials, printed)

Targeted drug strategies for cancer and inflammation by: (Language materials, printed)

Medicinal chemistry of anticancer drugs by: (Language materials, printed)

Lead compounds from medicinal plants for the treatment of cancer by: (Language materials, printed)

Biosensors and cancer by: (Language materials, printed)

Anticancer therapeutics by: (Language materials, printed)

Advances in DNA repair in cancer therapy by: (Language materials, printed)

Molecular mechanisms of tumor cell resistance to chemotherapy = targeted therapies to reverse resistance / by: (Language materials, printed)

Resistance to immunotherapeutic antibodies in cancer = strategies to overcome resistance / by: (Language materials, printed)

Cancer targeted drug delivery = an elusive dream / by: (Language materials, printed)

Therapeutic kinase inhibitors by: (Language materials, printed)

Imaging tumor response to therapy by: (Language materials, printed)

Cancer chemotherapy in clinical practice by: (Language materials, printed)

DNA topoisomerases and cancer by: (Language materials, printed)

Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy = Molecular Mechanisms and Clinical Applications / by: (Language materials, printed)

Apoptosis in carcinogenesis and chemotherapy = apoptosis in cancer / by: (Language materials, printed)

Cancer drug design and discovery by: (Language materials, printed)

Successes and limitations of targeted cancer therapy by: (Language materials, printed)

Resistance to targeted ABC transporters in cancer by: (Language materials, printed)

Handbook of anticancer drugs from marine origin by: (Language materials, printed)

Anti-cancer N-heterocyclic carbene complexes of gold(III), gold(I) and platinum(II) = thiol "switch-on" fluorescent probes, thioredoxin reductase inhibitors and endoplasmic reticulum targeting agents / by: (Language materials, printed)

Cancer drug discovery = science and history / by: (Language materials, printed)

Biodiversity, natural products and cancer treatment by: (Language materials, printed)

Anti-angiogenesis strategies in cancer therapeutics / by: (Language materials, printed)

Resistance to anti-cancer therapeutics targeting receptor tyrosine kinases and downstream pathways by: (Language materials, printed)

Rethinking platinum anticancer drug design = towards targeted and immuno-chemotherapeutic approaches / by: (Language materials, printed)

Mechanisms of drug resistance in cancer therapy by: (Language materials, printed)

Dose-finding designs for early-phase cancer clinical trials = a brief guidebook to theory and practice / by: (Language materials, printed)

Bioactive natural products for the management of cancer = from bench to bedside / by: (Language materials, printed)

Camptothecins in cancer therapy by: (Language materials, printed)

Combination cancer therapy = modulators and potentiators / by: (Language materials, printed)

Cancer chemotherapy, immunotherapy, and biotherapy = principles and practice / by: (Language materials, printed)

Advances in cancer drug targets.. Volume 3 by: (Language materials, printed)

Drug targets in cellular processes of cancer : = from nonclinical to preclinical models / by: (Language materials, printed)

Nanoparticle drug delivery systems for cancer treatment by: (Language materials, printed)

Cancer and vitamin C by: (Language materials, printed)

Therapeutic rhodium complexes by: (Language materials, printed)

Recent advances in signal transduction research and therapy.. Volume 1 by: (Language materials, printed)

Targeting lysine demethylases in cancer and other human diseases by: (Language materials, printed)

Cytokine and chemokine networks in cancer by: (Language materials, printed)

Harrison's manual of oncology by: (Language materials, printed)

PROTAC-mediated protein degradation = a paradigm shift in cancer therapeutics / by: (Language materials, printed)

New anti-cancer drug development and evaluation by: (Language materials, printed)